RELEGARD (BLANSETT PHARMACAL CO)


Welcome to the PulseAid listing for the RELEGARD drug offered from BLANSETT PHARMACAL CO. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: BLANSETT PHARMACAL CO
NON-PROPRIETARY NAME: GLACIAL ACETIC ACID, OXYQUINOLINE
SUBSTANCE NAME: ACETIC ACID; OXYQUINOLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00


RELEGARD HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRELEGARD from BLANSETT PHARMACAL CO
LABELER NAME: BLANSETT PHARMACAL CO
DEA SCHEDULE:
ACTIVE STRENGTH: .9; .025(mg/mL; mg/mL)
START MARKETING DATE: 2017-03-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51674-0130_85f9ed27-9fce-4cd5-9cb2-7dc9d6c06cb1
PRODUCT NDC: 51674-0130
APPLICATION NUMBER:

Other ACETIC ACID; OXYQUINOLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BLANSETT PHARMACAL CORELEGARD